drugset / Trial / NCT02468284

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

NCT02468284

Phase 1 Completed 15 enrolled Ferring Pharmaceuticals
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this trial is to look at how much a new trial drug get into body, such as when the drug concentration in your body reaches peak and how high the peak value is.

Timeline

Start
2015-07
Primary completion
2016-10-13
Completion
2017-10-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Degarelix Other / unclassified 80 mg

Indications